Uplift Model Warm-Start via Treatment Embeddings
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods of targeting treatments in software applications, such as A/B testing, are resource-intensive and time-consuming, and may not effectively identify user responses to new treatments.
Innovation Solution
An online system that maps existing treatments into a vector space based on their descriptions, allowing for the selection of similar existing treatments for new treatments, and targeting a subset of users based on the performance data of the selected treatments without the need for A/B testing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If A/B testing is used to evaluate new treatments, then user response accuracy can be measured, but resource consumption and time requirements increase significantly
Solution Approach 1:
The system performs preliminary actions by training an uplift model on historical treatment data before deploying new treatments. This pre-training enables the system to predict user responses to new treatments without conducting time-consuming A/B tests, thereby resolving the contradiction between measurement precision and time loss.
Solution Approach 2:
The system creates a digital copy of the treatment evaluation process through machine learning models. Instead of physically testing treatments on users (A/B testing), the system uses the uplift model to simulate and predict treatment effects, eliminating the need for lengthy experiments while maintaining prediction accuracy.
2Measurement precision
If A/B testing is used to evaluate new treatments, then user response accuracy can be measured, but resource consumption increases significantly
Solution Approach 1:
The system performs preliminary actions by training an uplift model on historical treatment data before deploying new treatments. This pre-training enables the system to predict user responses to new treatments without conducting resource-intensive A/B tests, thereby resolving the contradiction between measurement precision and resource consumption.
Solution Approach 2:
The system creates a digital copy of the treatment evaluation process through machine learning models. Instead of physically testing treatments on users (A/B testing), the system uses the uplift model to simulate and predict treatment effects, eliminating the need for lengthy experiments while maintaining prediction accuracy.
3Loss of information
If treatments are randomly assigned in A/B tests, then user response data can be collected, but user experience deteriorates due to bothersome tests
Solution Approach 1:
The system uses the uplift model to self-determine which users will benefit from treatments, eliminating the need for random assignment and A/B testing. The model autonomously predicts user responses and directs treatments only to likely responders, preserving data collection capabilities while eliminating the harmful effect of bothering users with unnecessary tests.
Solution Approach 2:
The system creates a digital copy of the treatment evaluation process through machine learning models. Instead of physically testing treatments on users (A/B testing), the system uses the uplift model to simulate and predict treatment effects, eliminating the need for lengthy experiments while maintaining prediction accuracy.
4Quantity of substance
If traditional uplift modeling is used without warm-start, then model training requires extensive data, but system complexity and training time increase
Solution Approach 1:
The system performs preliminary actions by pre-training the uplift model on historical treatment data before deploying new treatments. This warm-start approach allows the model to leverage existing knowledge and perform better with smaller amounts of new data, reducing both the volume of training data needed and the overall system complexity.
Data Source
AI summary
A system generates a set of embeddings for known treatments by applying a machine-learned embedding model to descriptions of the known treatments, where these embeddings form a vector space. The system generates an embedding for a new treatment and mapping it within the vector space, and identifies one or more known treatments with embeddings that exceed a similarity threshold with the new treatment embedding. The system accesses performance data for the selected known treatments to assess user response, and identifies a subset of users for the new treatment based on this performance data. The system also creates a content item that incorporates the new treatment, and transmits instructions to client devices of the targeted users to cause the client devices to display the content item.